These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

821 related items for PubMed ID: 10201607

  • 1. Topical nonpreserved methylprednisolone therapy for keratoconjunctivitis sicca in Sjögren syndrome.
    Marsh P, Pflugfelder SC.
    Ophthalmology; 1999 Apr; 106(4):811-6. PubMed ID: 10201607
    [Abstract] [Full Text] [Related]

  • 2. [Nonpreserved topical steroids and lacrimal punctal occlusion for severe keratoconjunctivitis sicca].
    Sainz De La Maza Serra M, Simón Castellvi C, Kabbani O.
    Arch Soc Esp Oftalmol; 2000 Nov; 75(11):751-756. PubMed ID: 11151264
    [Abstract] [Full Text] [Related]

  • 3. Recurrence after topical nonpreserved methylprednisolone therapy for keratoconjunctivitis sicca in Sjögren's syndrome.
    Hong S, Kim T, Chung SH, Kim EK, Seo KY.
    J Ocul Pharmacol Ther; 2007 Feb; 23(1):78-82. PubMed ID: 17341155
    [Abstract] [Full Text] [Related]

  • 4. Topical 0.1% prednisolone lowers nerve growth factor expression in keratoconjunctivitis sicca patients.
    Lee HK, Ryu IH, Seo KY, Hong S, Kim HC, Kim EK.
    Ophthalmology; 2006 Feb; 113(2):198-205. PubMed ID: 16360211
    [Abstract] [Full Text] [Related]

  • 5. Lacrimal punctum occlusion in the treatment of severe keratoconjunctivitis Sicca caused by Sjögren syndrome: a uniocular evaluation.
    Mansour K, Leonhardt CJ, Kalk WW, Bootsma H, Bruin KJ, Blanksma LJ, Sjögren Workgroup.
    Cornea; 2007 Feb; 26(2):147-50. PubMed ID: 17251802
    [Abstract] [Full Text] [Related]

  • 6. Long-term resolution of chronic dry eye symptoms and signs after topical cyclosporine treatment.
    Wilson SE, Perry HD.
    Ophthalmology; 2007 Jan; 114(1):76-9. PubMed ID: 17070588
    [Abstract] [Full Text] [Related]

  • 7. A randomized, double-masked, placebo-controlled, multicenter comparison of loteprednol etabonate ophthalmic suspension, 0.5%, and placebo for treatment of keratoconjunctivitis sicca in patients with delayed tear clearance.
    Pflugfelder SC, Maskin SL, Anderson B, Chodosh J, Holland EJ, De Paiva CS, Bartels SP, Micuda T, Proskin HM, Vogel R.
    Am J Ophthalmol; 2004 Sep; 138(3):444-57. PubMed ID: 15364229
    [Abstract] [Full Text] [Related]

  • 8. Systemic immunomodulatory therapy in severe dry eye secondary to inflammation.
    Cordero-Coma M, Anzaar F, Sobrin L, Foster CS.
    Ocul Immunol Inflamm; 2007 Sep; 15(2):99-104. PubMed ID: 17558834
    [Abstract] [Full Text] [Related]

  • 9. Comparison of efficacy and ocular surface toxicity of topical preservative-free methylprednisolone and preserved prednisolone in the treatment of acute anterior uveitis.
    Hedayatfar A, Hashemi H, Asgari S, Chee SP.
    Cornea; 2014 Apr; 33(4):366-72. PubMed ID: 24351572
    [Abstract] [Full Text] [Related]

  • 10. Altered cytokine balance in the tear fluid and conjunctiva of patients with Sjögren's syndrome keratoconjunctivitis sicca.
    Pflugfelder SC, Jones D, Ji Z, Afonso A, Monroy D.
    Curr Eye Res; 1999 Sep; 19(3):201-11. PubMed ID: 10487957
    [Abstract] [Full Text] [Related]

  • 11. Beneficial effect of topical fibronectin in patients with keratoconjunctivitis sicca of Sjögren's syndrome.
    Kono I, Matsumoto Y, Kono K, Ishibashi Y, Narushima K, Kabashima T, Yamane K, Sakurai T, Kashiwagi H.
    J Rheumatol; 1985 Jun; 12(3):487-9. PubMed ID: 4045849
    [Abstract] [Full Text] [Related]

  • 12. Ocular manifestations of Sjögren's syndrome: keratoconjunctivitis sicca.
    Friedlaender MH.
    Rheum Dis Clin North Am; 1992 Aug; 18(3):591-608. PubMed ID: 1496163
    [Abstract] [Full Text] [Related]

  • 13. Topical cyclosporine A in severe steroid-dependent childhood phlyctenular keratoconjunctivitis.
    Doan S, Gabison E, Gatinel D, Duong MH, Abitbol O, Hoang-Xuan T.
    Am J Ophthalmol; 2006 Jan; 141(1):62-66. PubMed ID: 16386977
    [Abstract] [Full Text] [Related]

  • 14. Preservative-free low-dose dexamethasone for the treatment of chronic ocular surface disease refractory to standard therapy.
    Jonisch J, Steiner A, Udell IJ.
    Cornea; 2010 Jul; 29(7):723-6. PubMed ID: 20489601
    [Abstract] [Full Text] [Related]

  • 15. Supratarsal triamcinolone injection in the treatment of superior limbic keratoconjunctivitis.
    Shen YC, Wang CY, Tsai HY, Lee YF.
    Cornea; 2007 May; 26(4):423-6. PubMed ID: 17457190
    [Abstract] [Full Text] [Related]

  • 16. [Topical cyclosporine A 0.05% in the treatment of keratoconjunctivitis sicca].
    Schrell C, Cursiefen C, Kruse F, Jacobi C.
    Klin Monbl Augenheilkd; 2012 May; 229(5):548-53. PubMed ID: 22189827
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of combined 0.05% cyclosporine and 1% methylprednisolone treatment for chronic dry eye.
    Byun YJ, Kim TI, Kwon SM, Seo KY, Kim SW, Kim EK, Park WC.
    Cornea; 2012 May; 31(5):509-13. PubMed ID: 19730097
    [Abstract] [Full Text] [Related]

  • 18. [Flow cytometry in impression cytology during keratoconjunctivitis sicca: effects of topical cyclosporin A on HLA DR expression].
    Galatoire O, Baudouin C, Pisella PJ, Brignole F.
    J Fr Ophtalmol; 2003 Apr; 26(4):337-43. PubMed ID: 12843889
    [Abstract] [Full Text] [Related]

  • 19. Topical cyclosporine A 0.5% as a possible new treatment for superior limbic keratoconjunctivitis.
    Perry HD, Doshi-Carnevale S, Donnenfeld ED, Kornstein HS.
    Ophthalmology; 2003 Aug; 110(8):1578-81. PubMed ID: 12917176
    [Abstract] [Full Text] [Related]

  • 20. The impact of topical cyclosporine A emulsion 0.05% on the outcomes of patients with keratoconjunctivitis sicca.
    Stonecipher K, Perry HD, Gross RH, Kerney DL.
    Curr Med Res Opin; 2005 Jul; 21(7):1057-63. PubMed ID: 16004673
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.